What are the payment terms?

We accept LC, T/T, D/P, PayPal, Small-amount payment, and Western Union.

What is the lead time for production?

The average lead time is 1-3 months for both peak and off-season periods.

18 Amlodipine Tablet Producing, Medicine GMP

Name: 18 Amlodipine Tablet Producing, Medicine GMP
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 2065121122

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.0001

1,000,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Application

Antipyretic and Anti-Inflammatory

State

Solid

Model NO.

10 tablets /blister

Shape

Tablet

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

300490

Drug Ad Approval No.

300490

COA

Available

Test Repot

Available

Register Dossier

Available

Period of Validity

3 Years

Transport Package

Blister

Specification

10tablets/box

Trademark

Origin

HS Code

2804100000

Production Capacity

5000000000000000000000PC/Year

Key features

GMP Certified Production: Manufactured under strict GMP standards ensuring high quality and safety.

Effective Hypertension Treatment: Calcium antagonist used for primary hypertension and angina pectoris.

Kidney Protective Effect: Provides protective benefits for kidneys during treatment.

Flexible Customization: Offers full customization, minor customization, and sample-based options.

Comprehensive Documentation: Provides COA, Test Report, and Register Dossier with 3-year validity.

Established Manufacturer: Factory established in 2001 with 20 years of export experience.

High Inspection Standards: 100% visual and function inspection for finished products.

Large Scale Production: 73,328 sqm plant area with 7 production lines and 153 employees.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.